These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5615694)

  • 21. [Experimental contribution on the question of lead decorporation by chelating agents].
    Catsch A
    Arzneimittelforschung; 1967 Apr; 17(4):493-5. PubMed ID: 5632447
    [No Abstract]   [Full Text] [Related]  

  • 22. [Differences in the distribution of radioactive beryllium chloride with and without a carrier in the body of rats when administered intratracheally].
    Kuznetsov AV; Matveev OG; Suntsov GD
    Gig Sanit; 1974 Oct; (10):113-4. PubMed ID: 4464201
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological intervention of tiferron and propolis to alleviate beryllium-induced hepatorenal toxicity.
    Nirala SK; Bhadauria M; Shukla S; Agrawal OP; Mathur A; Li PQ; Mathur R
    Fundam Clin Pharmacol; 2008 Aug; 22(4):403-15. PubMed ID: 18705751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative effectiveness of several aminoalkylphosphonic acids in eliminating beryllium from the body of rats].
    Ivannikov AT; Bugryshev PF; Kuznetsov AA
    Gig Tr Prof Zabol; 1972 Apr; 16(4):55-7. PubMed ID: 5044693
    [No Abstract]   [Full Text] [Related]  

  • 25. [Oxidation processes in the lungs of rats following poisoning by beryllium compounds].
    Karamzina NM; Pavlova IV
    Gig Tr Prof Zabol; 1966 Sep; 16(9):32-6. PubMed ID: 6001338
    [No Abstract]   [Full Text] [Related]  

  • 26. Chelating agents in the therapy of beryllium poisoning.
    CASH R; SHAPIRO RI; LEVY SH; HOPKINS SM
    N Engl J Med; 1959 Apr; 260(14):683-6. PubMed ID: 13644567
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of chelating agents and antioxidants in beryllium induced toxicity.
    Johri S; Shukla S; Sharma P
    Indian J Exp Biol; 2002 May; 40(5):575-82. PubMed ID: 12622205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the effectiveness of cleansing the skin of beryllium compounds].
    Andreeva NA; Sit'ko RIa; Khodyreva MA
    Gig Sanit; 1982 Mar; (3):87-8. PubMed ID: 7084730
    [No Abstract]   [Full Text] [Related]  

  • 29. The significance of beryllium concentrations in urine.
    Lieben J; Dattoli JA; Vought VM
    Arch Environ Health; 1966 Mar; 12(3):331-4. PubMed ID: 5904511
    [No Abstract]   [Full Text] [Related]  

  • 30. Amelioration of beryllium induced alterations in hepatorenal biochemistry and ultramorphology by co-administration of tiferron and adjuvants.
    Nirala SK; Bhadauria M; Mathur R; Mathur A
    J Biomed Sci; 2007 May; 14(3):331-45. PubMed ID: 17278010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Test of the use of beryllium for the study of the activity of the reticuloendothelial system (RES)].
    Vacher J
    Ann Inst Pasteur (Paris); 1968 Nov; 115(5):922-40. PubMed ID: 5725434
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of chelating agents on the toxicity and distribution of beryllium in rats.
    Shukla S; Sharma P; Johri S; Mathur R
    J Appl Toxicol; 1998; 18(5):331-5. PubMed ID: 9804433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glycolysis activity in rat lung homogenate in poisonings caused by the administration of beryllium bronze, copper and beryllium oxide].
    Surikova SP; Pavlova IV; Gaĭdova ES; Bobrishchev-Pushkin DM
    Gig Tr Prof Zabol; 1974 Sep; (9):48-51. PubMed ID: 4465203
    [No Abstract]   [Full Text] [Related]  

  • 34. [Autoallergic reaction in the heart of experimental animals exposed to beryllium oxide (BeO) and chloride (BeC12)].
    Litvinov NN; Popov VA
    Gig Tr Prof Zabol; 1982 Aug; (8):39-42. PubMed ID: 7129192
    [No Abstract]   [Full Text] [Related]  

  • 35. [Limits of beryllium detection with laser microprobe mass spectrometry (LAMMS)].
    Entzian P; Pawelek W; Lindner B; Schlaak M; Zabel P; Müller-Quernheim J
    Pneumologie; 1998 Dec; 52(12):674-9. PubMed ID: 10028838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of beryllium in biological samples by accelerator mass spectrometry: applications for studying chronic beryllium disease.
    Chiarappa-Zucca ML; Finkel RC; Martinelli RE; McAninch JE; Nelson DO; Turteltaub KW
    Chem Res Toxicol; 2004 Dec; 17(12):1614-20. PubMed ID: 15606137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acid-base equilibrium in the experimental effect of beryllium].
    Charykchiev DD; Mukhina ST
    Gig Tr Prof Zabol; 1968 Dec; 12(12):52-3. PubMed ID: 5731087
    [No Abstract]   [Full Text] [Related]  

  • 38. [Berylliosis in Italy: a case of "sarcoidosis" under the threshold limit value].
    Contini S; Mattioli G; Berretta F; Bergamaschi A; Sullotto F; Spigo A; Verniano P; Amicosante M
    Med Lav; 2006; 97(4):592-6. PubMed ID: 17017386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designer ligands for beryllium.
    Keizer TS; Sauer NN; McCleskey TM
    J Am Chem Soc; 2004 Aug; 126(31):9484-5. PubMed ID: 15291520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of chloracetophos, an organic phosphorus preparation on reparative osteogenesis in experiments on rabbits].
    Bogdanovich UIa; Veselovskiĭ DA; Spektor IM
    Patol Fiziol Eksp Ter; 1968; 12(4):54-6. PubMed ID: 5747000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.